US 12163168
Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
granted A61KA61K31/198A61K31/401
Quick answer
US patent 12163168 (Engineered primate cystine/cysteine degrading enzymes for therapeutic uses) held by The Board of Regents of the University of Texas System expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/198, A61K31/401, A61K33/00, A61K38/00